Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CorMedix (CRMD) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for CorMedix (CRMD) over the last 12 years, with Q3 2025 value amounting to -$72727.0.

  • CorMedix's Other Non Operating Income fell 11823.56% to -$72727.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$107194.0, marking a year-over-year decrease of 12472.94%. This contributed to the annual value of $520000.0 for FY2024, which is 189347.45% up from last year.
  • CorMedix's Other Non Operating Income amounted to -$72727.0 in Q3 2025, which was down 11823.56% from -$16295.0 recorded in Q2 2025.
  • In the past 5 years, CorMedix's Other Non Operating Income ranged from a high of $530964.0 in Q2 2023 and a low of -$72727.0 during Q3 2025
  • Over the past 5 years, CorMedix's median Other Non Operating Income value was -$4340.0 (recorded in 2021), while the average stood at $89405.4.
  • As far as peak fluctuations go, CorMedix's Other Non Operating Income tumbled by 1466052.63% in 2021, and later soared by 450871.06% in 2023.
  • CorMedix's Other Non Operating Income (Quarter) stood at -$11066.0 in 2021, then surged by 1729.11% to $180277.0 in 2022, then plummeted by 116.2% to -$29199.0 in 2023, then soared by 168.5% to $20000.0 in 2024, then tumbled by 463.64% to -$72727.0 in 2025.
  • Its Other Non Operating Income stands at -$72727.0 for Q3 2025, versus -$16295.0 for Q2 2025 and -$38172.0 for Q1 2025.